organisation current research and strategies 2011 - 2012 - eortc

Por um escritor misterioso

Descrição

organisation current research and strategies 2011 - 2012 - eortc
organisation current research and strategies 2011 - 2012 - eortc
Quality of survival the 1st year with glioblastoma: a longitudinal study of patient-reported quality of life in: Journal of Neurosurgery Volume 124 Issue 4 (2016) Journals
organisation current research and strategies 2011 - 2012 - eortc
Antibiotics, Free Full-Text
organisation current research and strategies 2011 - 2012 - eortc
Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions - ScienceDirect
organisation current research and strategies 2011 - 2012 - eortc
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022 in: Journal of the National Comprehensive Cancer Network Volume 20 Issue 11 (2022)
organisation current research and strategies 2011 - 2012 - eortc
EORTC QLQ-C30 functional scales and global quality of life: mean
organisation current research and strategies 2011 - 2012 - eortc
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
organisation current research and strategies 2011 - 2012 - eortc
EORTC QLQ-C30 (version 3). For permission to use, contact: Quality of
organisation current research and strategies 2011 - 2012 - eortc
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study - The Lancet Oncology
organisation current research and strategies 2011 - 2012 - eortc
Cancers, Free Full-Text
organisation current research and strategies 2011 - 2012 - eortc
An integrated approach to cardioprotection in lymphomas - The Lancet Haematology
organisation current research and strategies 2011 - 2012 - eortc
organisation current research and strategies 2011 - 2012 - eortc
organisation current research and strategies 2011 - 2012 - eortc
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
de por adulto (o preço varia de acordo com o tamanho do grupo)